Trans Fatty Acids, Dyslipidemia, and Cardiovascular Disease Edmond K. Kabagambe Frank A. Franklin Trans fatty acids are unsaturated fatty acids in which the hydrogen molecules at one or more of…
Dietary Treatment of Dyslipidemia Virginia W. Hartmuller Extensive evidence exists from population studies and clinical trials for the association between many dietary factors and blood lipid levels and the risk…
Lipoprotein (A): A Pleotropic Risk Factor for Cardiovascular Disease Ernst J. Schaefer Mary E. Herman Jennifer J. Jenner Leo J. Seman In this chapter we review the current state of…
Other Nontraditional Risk Factors for Cardiovascular Disease Simeon Margolis It is relatively easy to decide how aggressively to pursue preventive measures in people at low risk (no risk factors) and…
Apob and the Atherogenic Apob Dyslipoproteinemias Allan D. Sniderman Jacqueline P. De Graaf Patrick Couture Vascular disease remains the greatest cause of death in the developed countries and has reached…
Clinical Utility of Inflammatory Markers Kiran Musunuru Samia Mora High-sensitivity C-reactive protein (hsCRP) testing is inexpensive and has been shown to (a) predict cardiovascular risk in multiple patient groups; (b)…
Dyslipidemia in the Elderly: Special Insights to Inform the Management Strategy Michael H. Shannon William R. Hazzard The progressive and dramatic aging of the American population over the last century,…
Dyslipidemia and Atherosclerosis in Women Christian D. Nagy Catherine Y. Campbell Roger S. Blumenthal Cardiovascular disease (CVD) remains the number one killer of American women and coronary heart disease (CHD)…
Dyslipidemia in Children and Adolescents Peter O. Kwiterovich Jr. Sarah B. Clauss Brian W. McCrindle This chapter presents a theoretical and practical approach to the diagnosis and treatment of dyslipidemia…
Dyslipidemia in Renal Disease Jeffrey M. Saland Rulan S. Parekh Dyslipidemias have been commonly described in patients with chronic kidney disease (CKD) since the 1960s, with case reports demonstrating markedly…
